No Data
No Data
Goldman Sachs: Maintains Buy rating on NEW ORIENTAL-S and raises Target Price to 42 HKD.
Goldman Sachs issued a Research Report stating that it will maintain a Buy rating on NEW ORIENTAL-S (09901), with the Target Price raised to HKD 42 based on the sum-of-the-parts valuation method (SOTP). If the company can achieve the guidance for margin expansion in the May quarter, the firm expects investor confidence to gradually improve, and the valuation multiple of NEW ORIENTAL's core Business will slowly increase from the current 1 times 12-month forward PE. The firm gained confidence from the NEW ORIENTAL February quarterly Earnings Reports conference call, where management emphasized its focus on cost control and enhancing operational efficiency, and projected the operating profit margin of NEW ORIENTAL's core Business for the May quarter and the 26 fiscal year.
On April 15, A-shares investment warning | CCCG Real Estate Corporation: net loss of 5.179 billion yuan for the year 2024.
Luoxin Pharmaceuticals Group Stock reported a net loss of 0.962 billion yuan for 2024; Yunnan Coal & Energy reported a net loss of 0.662 billion yuan for 2024; CCCG Real Estate Corporation reported a net loss of 5.179 billion yuan for 2024; Shanxi Guoxin Energy Corporation reported a net loss of 0.34 billion yuan for 2024; Beijing Tongtech received a notice of investigation from the Securities Regulatory Commission due to suspected false records in periodic reports and other financial data; Bidder Pharmaceuticals has terminated its plan to issue shares to purchase assets and raise supporting funds; *ST Oriental received a prior notice of intention to terminate the listing of its stocks; Hainan Shuangcheng Pharmaceuticals' stock trading may be subject to delisting risk warning after the disclosure of the 2024 annual report.
*Special Treat Dongfang (600811.SH): Received a notice of intent to terminate the company's Stocks listing.
On April 14, 2025, *ST Orient (600811.SH) announced that it received a prior notice from the Shanghai Stock Exchange regarding the proposed termination of the listing of Orient Group Incorporation's Stocks (Letter No. 0377 [2025] from the Shanghai Stock Exchange, hereinafter referred to as the "Prior Notice"). In accordance with relevant regulations, the content of the "Prior Notice" is announced as follows: As of April 14, 2025, your company's Stocks have closed below 1 yuan for 20 consecutive trading days, according to the "Shanghai Stock Exchange Stocks Listing Rules (April 2024).
*ST Dongfang (600811.SH): The company's Stocks have reached the threshold for (Delisted) due to Trading, and trading has been suspended.
On April 14, 2023, *ST Dongfang (600811.SH) announced that as of April 14, 2025, the closing price of the company's Stocks was 0.36 yuan per share, having been below 1 yuan per share for 20 consecutive Trading days. According to Article 9.2.1, item 1 of the Stock Listing Rules, the company's Stocks have reached the conditions for delisting, and trading may be terminated by the Shanghai Stock Exchange. According to relevant regulations, the company's Stocks will be suspended from trading starting from the opening of the market on April 15, 2025.
Brokerage morning meeting highlights: Countermeasures against tariffs boost Shenzhen Agricultural Products Group prices, the planting chain directly benefits.
At today's Brokerage morning meeting, CITIC SEC believes that countermeasures against tariffs boost the prices of Shenzhen Agricultural Products Group, which directly benefits the planting chain; HAITONG SEC proposed a bullish view on the relative yields of the Banks Sector in April; Galaxy Securities stated that it focuses on Gold and countermeasures against rare earths.
*Special Treat Dongfang (600811.SH) may face the risk of being delisted due to its stock price falling below 1 yuan.
*Special Treat Dongfang (600811.SH) announced that the closing price of the company's Stocks on April 7, 2025, is 0.4...